The breast cancer 'breakthrough' is a story of overtreatment, not a triumph of testing, says Dr Clare Craig. The truth is, the genetic test failed, but it's being rolled out anyway.
The post The Breast Cancer ‘Breakthrough’ is a Story of Overtreatment Not a Triumph of Testing appeared first on The Daily Sceptic.
The rise of weight-loss injections has transformed obesity treatment in a way few experts predicted just a few years ago. Medications such as Wegovy, Ozempic, Zepbound, and Mounjaro have helped many people lose substantial amounts of weight when diet and exercise alone were not enough. Now, researchers have uncovered evidence suggesting that these medicines may […]
The post Could Weight-Loss Injections Help Fight Cancer? appeared first on Knowridge Science Report.
Modern cancer treatment is entering a new era. Scientists are developing medicines that are far more precise than traditional chemotherapy, offering patients new hope and better outcomes. Among the most promising innovations are antibody-drug conjugates, a type of treatment that has rapidly become an important part of cancer care. These therapies are designed to act […]
The post New Cancer Treatments Bring Hope but Also Hidden Dangers appeared first on Knowridge Science Report.
For many years, people have been told that some fats are healthier than others. Olive oil, for example, is often praised as a heart-friendly food and is a key part of the Mediterranean diet. Because of this reputation, many people assume that foods rich in olive oil are beneficial for overall health. However, a new […]
The post Could a ‘Healthy’ Fat Help Pancreatic Cancer Grow? appeared first on Knowridge Science Report.
One of the greatest challenges in cancer treatment is drug resistance. A treatment may work well at first, shrinking tumors and slowing disease progression, but over time cancer cells can adapt and learn how to survive. This problem is especially common in advanced kidney cancer, where many patients eventually run out of effective treatment options. […]
The post New Therapy May Beat Drug Resistance in Advanced Kidney Cancer appeared first on Knowridge Science Report.
Medications such as Ozempic, Wegovy, Mounjaro, and Zepbound have become household names in recent years. Originally developed to help people with type 2 diabetes control their blood sugar levels, these drugs later gained enormous attention because of their ability to help people lose significant amounts of weight. Millions of people now use them, and doctors […]
The post Could Popular Weight Loss Drugs Prevent Breast Cancer? appeared first on Knowridge Science Report.
Modern cancer treatment has entered a new era thanks to immunotherapy. Instead of directly attacking cancer cells with chemicals or radiation, immunotherapy encourages the immune system to do the job itself. This approach has helped many patients live longer and has changed the outlook for several types of cancer. One of the most widely used […]
The post Scientists Find a Smarter Way to Track Cancer and Heart Damage appeared first on Knowridge Science Report.
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way to attack tumors that have remained difficult to treat. Small cell neuroendocrine cancers can develop in the lungs, prostate, [...]
When people think about healthy eating, fat often becomes a confusing topic. For decades, many health experts focused on reducing overall fat intake. More recently, attention shifted toward choosing healthier fats rather than simply eating less fat. Olive oil became one of the most celebrated examples because of its connection to heart health and the […]
The post Can Fish Oil or Olive Oil Boost Pancreatic Cancer Growth? appeared first on Knowridge Science Report.
Cancer’s most notorious growth protein may also be helping tumors survive chemotherapy. A protein already known for fueling cancer growth may have another troubling ability: helping damaged tumor cells repair their DNA and survive treatments designed to destroy them. Researchers at Oregon Health & Science University (OHSU) report that MYC, a protein that is overactive [...]
The mystery of the Greenland shark’s incredible longevity may finally be unraveling, as a team of international researchers has completed the first comprehensive genome map of the creature.
Native to the cold waters between Greenland, Iceland, and Canada, Greenland sharks boast one of the longest vertebrate lifespans on Earth, approaching 400 years. In a recent paper published in the Proceedings of the National Academy of Sciences, researchers led by Shigeharu Kinoshita of the University of Tokyo have identified some of the genetic basis of that extraordinary lifespan, which they say future researchers may exploit to treat cancer and age-related illnesses.
As genetic sequencing technology has improved and costs have fallen, there has been a major increase in the number of sequences from long-lived species for comparative analysis. Discoveries have included identifying increases in genes related to the immune system and growth hormone receptors in rockfish and bat species noted for their longevity.
With an entire lifecycle in slow motion, Greenland sharks’ longevity can be traced to their prolonged development: they take 150 years to reach sexual maturity, growing only 1 centimeter per year. Despite being one of the slowest swimmers in the ocean, the species undertakes large-scale migrations spanning over 1,000 kilometers.
Large genome sizes, like those of the Greenland shark, pose enormous mapping challenges, full of many repetitive sequences. Despite their importance for management and conservation, few whale and shark species have been sequenced due to the difficulty involved. To fill data gaps in the genetic causes of longevity, aquatic species evolution, and the risks of biodiversity loss, the team chose the Greenland shark as their subject.
The University of Tokyo-led team mapped roughly 5.9 billion DNA base pairs, accounting for 96.7% of the shark’s genome. Among the discoveries were the identification of specific genetic features likely related to the Greenland shark’s longevity.
In their paper, they wrote of discovering “genetic traits associated with cancer, immune response function, genome stability, and cardiac function, deep-sea adaptations, and population size dynamics,” in the new research.
One of the most crucial of these traits is how the shark appears to mitigate the genetic strain that contributes to aging by stabilizing the building blocks of chromosomes. Chromatin is a structure consisting of DNA, RNA, and proteins, which makes up chromosomes.
In the Greenland shark, the histone H1.0 protein, which binds DNA in chromatin, undergoes an amino acid substitution that may enhance stability and reduce the effects of aging.
Another genetic tool aiding the shark’s longevity is the presence of 59 copies of the FTH1b gene, which researchers discovered on pseudochromosome 33, far above the number seen in other shark or fish species. This helps regulate ferroptosis, a form of programmed cell death, thereby mitigating cell damage. Since the gene controls iron storage and ferroptosis is iron-dependent, the researchers say this multiplication of FTH1b could prevent oxidative cell damage.
Beyond those specific expressions, researchers also found expansion of entire gene families associated with DNA repair, immune functions, and cancer resistance.
Although limited to a single species, the research does advance general understanding of the genetic factors involved in extended lifespans. However, it will be up to future researchers to identify how this new information can be applied to human concerns.
The paper, “The Greenland Shark Genome: Insights into Lifespan Extremes and Population Dynamics,” appeared in Earth and Planetary Science Letters on May 19, 2026.
Ryan Whalen covers science and technology for The Debrief. He holds an MA in History and a Master of Library and Information Science with a certificate in Data Science. He can be contacted at ryan@thedebrief.org, and follow him on Twitter @mdntwvlf.
A gene normally responsible for repairing DNA may have a darker side when produced in excess. Cancer treatment is increasingly moving beyond where a tumor forms and focusing instead on the genetic flaws that drive it. Now, researchers at Penn State College of Medicine have identified an unexpected DNA repair gene that could help expand [...]
A vitamin D-based therapy may help remodel the protective barrier surrounding pancreatic tumors, offering a potential new treatment strategy. Pancreatic cancer is notoriously difficult to treat in part because tumors surround themselves with a dense, protective barrier that blocks drugs and suppresses immune activity. Now, a small clinical trial led by researchers at Dana-Farber Cancer [...] 
Login